Schmacht D C, Back M R, Novotney M L, Johnson B L, Bandyk D F
Division of Vascular Surgery, University of South Florida College of Medicine, Harbourside Medical Tower #650, 4 Columbia Dr., Tampa, FL 33606, USA.
Vasc Surg. 2001 Sep-Oct;35(5):353-9. doi: 10.1177/153857440103500505.
Multimodal (thrombolysis, surgical decompression, venous reconstruction, oral anticoagulation) treatment of primary axillary-subclavian venous thrombosis was reviewed to assess the impact of venous patency on functional outcome. Since 1996, 7 patients (6 men, 1 woman) of ages 16-53 years (mean 33 years) presented with symptomatic acute axillosubclavian venous thrombosis as a result of a recent athletic or strenuous arm activity. Five patients had undergone previous (>2 weeks) catheter-directed thrombolysis and venous angioplasty. Diagnostic contrast venography followed by repeat catheter-directed thrombolysis demonstrated abnormal (residual stenosis [n=6] or occlusion [n=1]) axillosubclavian venous segments in all patients. Surgical intervention was performed at a mean interval of 7 days (range 1-19 days) after thrombolysis and consisted of thoracic outlet decompression with scalenectomy and 1st rib resection via a paraclavicular (n=4) or supraclavicular (n=3) approach. Medial claviculectomy or cervical rib resection was performed in 2 patients. Concomitant venous surgery was performed in all patients to restore normal venous patency by circumferential venolysis (n=7) and balloon catheter thrombectomy (n=3), or vein-patch angioplasty (n=2), or endovenectomy (n=5), or internal jugular transposition (n=2). Postoperative venous duplex testing beyond 1 month identified recurrent thrombosis in 4 patients despite therapeutic oral anticoagulation. Subsequent venous recanalization was documented in 3 patients. Poor functional outcome was associated with an occluded venous repair and extensive venous thrombosis on initial presentation. A patent or recanalized venous repair present in 6 of 7 patients was associated with good functional outcome and may justify multimodal intervention in patients with primary axillosubclavian effort thrombosis presenting with recurrent thrombosis and significant residual disease after thrombolysis.
回顾了原发性腋-锁骨下静脉血栓形成的多模式治疗(溶栓、手术减压、静脉重建、口服抗凝),以评估静脉通畅对功能结局的影响。自1996年以来,7例患者(6例男性,1例女性),年龄16 - 53岁(平均33岁),因近期运动或剧烈手臂活动出现有症状的急性腋-锁骨下静脉血栓形成。5例患者曾接受过(>2周)导管定向溶栓和静脉血管成形术。诊断性静脉造影后重复导管定向溶栓显示,所有患者的腋-锁骨下静脉段均异常(残余狭窄[n = 6]或闭塞[n = 1])。溶栓后平均7天(范围1 - 19天)进行手术干预,包括通过锁骨旁(n = 4)或锁骨上(n = 3)入路行胸廓出口减压,切除斜角肌和第1肋。2例患者进行了内侧锁骨切除术或颈肋切除术。所有患者均进行了同期静脉手术,通过环周静脉溶解术(n = 7)、球囊导管血栓切除术(n = 3)、静脉补片血管成形术(n = 2)、内膜切除术(n = 5)或颈内静脉转位术(n = 2)恢复正常静脉通畅。尽管进行了治疗性口服抗凝,但术后1个月以上的静脉双功超声检查发现4例患者出现复发性血栓形成。3例患者有随后的静脉再通记录。功能结局差与静脉修复闭塞和初始表现时广泛的静脉血栓形成有关。7例患者中有6例存在通畅或再通的静脉修复与良好的功能结局相关,这可能证明对原发性腋-锁骨下用力性血栓形成且溶栓后出现复发性血栓形成和明显残余病变的患者进行多模式干预是合理的。